• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大流行早期纬度、日照时长和维生素D状况与新冠肺炎发病率及死亡率的关联:对187个国家的全球分析

Early pandemic associations of latitude, sunshine duration, and vitamin D status with COVID-19 incidence and fatalities: A global analysis of 187 Countries.

作者信息

Mogire Reagan M

机构信息

Center for Clinical Research, Kenya Medical Research Institute (KEMRI), Kisumu, Kenya.

出版信息

PLOS Glob Public Health. 2025 Jul 28;5(7):e0004074. doi: 10.1371/journal.pgph.0004074. eCollection 2025.

DOI:10.1371/journal.pgph.0004074
PMID:40720505
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12303322/
Abstract

In the face of the COVID-19 pandemic, understanding the interplay between environmental factors and virus spread is crucial for global preparedness strategies. This study explores how geographic latitude, sunshine duration, and vitamin D status were associated with the incidence and fatality rates of COVID-19 across 187 countries during the crucial early months of the outbreak. Data on the total number of COVID-19 cases by country were obtained from the COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) as of June 30, 2020. Univariate and multivariate regression analyses were conducted to determine the associations between COVID-19 cases and latitude, average hours of sunshine from January to June, and mean 25-hydroxyvitamin D (25(OH)D) levels. The average COVID-19 cumulative incidence and mortality per million population were 2,087 and 69, respectively, with a case fatality rate of 3.19%. COVID-19 case fatality rate was positively associated with latitude (β = 0.030; 95% CI: 0.008, 0.052) and negatively associated with hours of sunshine (β = -1.51; 95% CI: -4.44, 1.41) and 25(OH)D levels (β = -0.054; 95% CI: -0.089, -0.019) in adjusted linear regression analyses. Findings were similar for COVID-19 cumulative incidence and mortality rate. These findings indicate that higher latitude and lower 25(OH)D levels were associated with increased COVID-19 severity and mortality. While the data highlight potential links between vitamin D status and COVID-19 outcomes, causality cannot be inferred.

摘要

面对新冠疫情,了解环境因素与病毒传播之间的相互作用对于全球防范策略至关重要。本研究探讨了在疫情爆发关键的最初几个月里,地理纬度、日照时长和维生素D水平如何与187个国家的新冠发病率和死亡率相关。截至2020年6月30日,各国新冠病例总数的数据来自系统科学与工程中心(CSSE)的新冠数据存储库。进行了单变量和多变量回归分析,以确定新冠病例与纬度、1月至6月的平均日照时长以及平均25-羟基维生素D(25(OH)D)水平之间的关联。每百万人口的新冠累计发病率和死亡率平均分别为2087例和69例,病死率为3.19%。在调整后的线性回归分析中,新冠病死率与纬度呈正相关(β = 0.030;95%置信区间:0.008,0.052),与日照时长呈负相关(β = -1.51;95%置信区间:-4.44,1.41),与25(OH)D水平呈负相关(β = -0.054;95%置信区间:-0.089,-0.019)。新冠累计发病率和死亡率的结果相似。这些发现表明,较高的纬度和较低的25(OH)D水平与新冠严重程度和死亡率增加有关。虽然数据突出了维生素D水平与新冠结果之间的潜在联系,但无法推断因果关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282f/12303322/51d3acec63d9/pgph.0004074.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282f/12303322/391f46cd6166/pgph.0004074.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282f/12303322/51d3acec63d9/pgph.0004074.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282f/12303322/391f46cd6166/pgph.0004074.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282f/12303322/51d3acec63d9/pgph.0004074.g002.jpg

相似文献

1
Early pandemic associations of latitude, sunshine duration, and vitamin D status with COVID-19 incidence and fatalities: A global analysis of 187 Countries.大流行早期纬度、日照时长和维生素D状况与新冠肺炎发病率及死亡率的关联:对187个国家的全球分析
PLOS Glob Public Health. 2025 Jul 28;5(7):e0004074. doi: 10.1371/journal.pgph.0004074. eCollection 2025.
2
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
3
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
4
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
5
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
6
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
7
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Effects of city design on transport mode choice and exposure to health risks during and after a crisis: a retrospective observational analysis.危机期间及之后城市设计对交通方式选择和健康风险暴露的影响:一项回顾性观察分析
Lancet Planet Health. 2025 Jun;9(6):e467-e479. doi: 10.1016/S2542-5196(25)00088-9.
10
Vitamin D supplementation for chronic liver diseases in adults.成人慢性肝病的维生素D补充治疗
Cochrane Database Syst Rev. 2017 Nov 3;11(11):CD011564. doi: 10.1002/14651858.CD011564.pub2.

本文引用的文献

1
Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT).维生素 D 补充剂的检测与治疗方法对全因急性呼吸道感染和 COVID-19 风险的影响:3 期随机对照试验(CORONAVIT)。
BMJ. 2022 Sep 7;378:e071230. doi: 10.1136/bmj-2022-071230.
2
Lifting of COVID-19 restrictions in the UK and the Delta variant.英国新冠疫情限制措施的解除与德尔塔变种
Lancet Respir Med. 2021 Aug;9(8):e85. doi: 10.1016/S2213-2600(21)00328-3. Epub 2021 Jul 12.
3
Socio-Demographic and Knowledge-Related Determinants of Vitamin D Supplementation in the Context of the COVID-19 Pandemic: Assessment of an Educational Intervention.
新冠疫情背景下维生素D补充的社会人口学及知识相关决定因素:一项教育干预措施的评估
Front Nutr. 2021 Jun 2;8:648450. doi: 10.3389/fnut.2021.648450. eCollection 2021.
4
Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.一项随机临床试验:单次高剂量维生素 D3 对中重度 COVID-19 患者住院时间的影响。
JAMA. 2021 Mar 16;325(11):1053-1060. doi: 10.1001/jama.2020.26848.
5
Vaccines are curbing COVID: Data from Israel show drop in infections.疫苗正在遏制新冠疫情:以色列的数据显示感染人数下降。
Nature. 2021 Feb;590(7845):197. doi: 10.1038/d41586-021-00316-4.
6
Africa's low COVID-19 mortality rate: A paradox?非洲 COVID-19 死亡率低:一个悖论?
Int J Infect Dis. 2021 Jan;102:118-122. doi: 10.1016/j.ijid.2020.10.038. Epub 2020 Oct 16.
7
Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries.新冠大流行第一波对 21 个工业化国家全因死亡率影响的规模、人口统计学特征和动态。
Nat Med. 2020 Dec;26(12):1919-1928. doi: 10.1038/s41591-020-1112-0. Epub 2020 Oct 14.
8
"Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study"."骨化三醇治疗和最佳现有治疗与最佳现有治疗对因 COVID-19 住院患者入住重症监护病房和死亡的影响:一项前瞻性随机临床研究"。
J Steroid Biochem Mol Biol. 2020 Oct;203:105751. doi: 10.1016/j.jsbmb.2020.105751. Epub 2020 Aug 29.
9
Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis.心血管疾病与其他 10 种预先存在的合并症与 COVID-19 死亡率的关联:系统评价和荟萃分析。
PLoS One. 2020 Aug 26;15(8):e0238215. doi: 10.1371/journal.pone.0238215. eCollection 2020.
10
Vitamin D Supplementation During the COVID-19 Pandemic.2019冠状病毒病大流行期间的维生素D补充
Mayo Clin Proc. 2020 Aug;95(8):1804-1805. doi: 10.1016/j.mayocp.2020.05.036. Epub 2020 Jun 6.